Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CURX
ENSC
Add up to 3 more stocks
CURX
Curanex Pharmaceuticals Inc Common Stock
+1.41%
$5.03+0.07Delayed quote: Oct 6, 2026, 11:01 AM EDT
Market Cap
$7.13M
52W Range
$3.58 - $16.94
ENSC
Ensysce Biosciences, Inc.
-0.07%
$0.42-0.00Delayed quote: Oct 6, 2026, 11:03 AM EDT
Market Cap
$6.43M
52W Range
$0.23 - $2.75
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.49 | N/A |
| P/S Ratio | N/A | 5.53 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | -1084.2% |
| ROE | -218.7% | N/A |
| ROA | -206.3% | -426.9% |
| ROIC | -208.4% | N/A |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 45.95 | 0.70 |
| Quick Ratio | 45.95 | N/A |
| Debt/Equity | 0.06 | N/A |
| Interest Coverage | -496.55 | -545.69 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.